These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammation in atherosclerosis: transition from theory to practice. Libby P; Okamoto Y; Rocha VZ; Folco E Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609 [TBL] [Abstract][Full Text] [Related]
3. Macrophages and dendritic cells: the usual suspects in atherogenesis. Kassiteridi C; Monaco C Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566 [TBL] [Abstract][Full Text] [Related]
4. Functional diversity of macrophages in vascular biology and disease. Park I; Kassiteridi C; Monaco C Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468 [TBL] [Abstract][Full Text] [Related]
5. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. Maurizi G; Della Guardia L; Maurizi A; Poloni A J Cell Physiol; 2018 Jan; 233(1):88-97. PubMed ID: 28181253 [TBL] [Abstract][Full Text] [Related]
6. Role for TNF in atherosclerosis? Lessons from autoimmune disease. McKellar GE; McCarey DW; Sattar N; McInnes IB Nat Rev Cardiol; 2009 Jun; 6(6):410-7. PubMed ID: 19421244 [TBL] [Abstract][Full Text] [Related]
7. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326 [TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis and immunity: A perspective. Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470 [TBL] [Abstract][Full Text] [Related]
9. Targeting the immune response in atherosclerosis: It's time for clinical trials! Joffre J; Ait-Oufella H Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009 [No Abstract] [Full Text] [Related]
10. Immunometabolism of AMPK in insulin resistance and atherosclerosis. Fullerton MD; Steinberg GR; Schertzer JD Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321 [TBL] [Abstract][Full Text] [Related]
11. Role of inflammatory cells and toll-like receptors in atherosclerosis. Seneviratne AN; Monaco C Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491 [TBL] [Abstract][Full Text] [Related]
12. Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance. Fitzgibbons TP; Czech MP J Mol Med (Berl); 2016 Mar; 94(3):267-75. PubMed ID: 26847458 [TBL] [Abstract][Full Text] [Related]
13. Inflammation and atherosclerosis: what is on the horizon? Ruparelia N; Choudhury R Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811 [No Abstract] [Full Text] [Related]
18. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway. Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559 [TBL] [Abstract][Full Text] [Related]
19. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Suganami T; Nishida J; Ogawa Y Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2062-8. PubMed ID: 16123319 [TBL] [Abstract][Full Text] [Related]